References
- Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 235–242
- Harris N L, Jaffe E S, Diebold J, Flandrin G, Muller-Hermelink H K, Vardiman J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835–3849
- Ferreri A J, Campo E, Seymour J F, Willemze R, Ilariucci F, Ambrosetti A, et al. Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’. Br J Haematol 2004; 127: 173–183
- Ponzoni M, Ferreri A J. Intravascular lymphoma: a neoplasm of ‘homeless’ lymphocytes?. Hematol Oncol 2006; 24: 105–112
- Zuckerman D, Seliem R, Hochberg E. Intravascular lymphoma: the oncologist's “great imitator”. Oncologist 2006; 11: 496–502
- Ferreri A J, Campo E, Ambrosetti A, Ilariucci F, Seymour J F, Willemze R, et al. Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma. Ann Oncol 2004; 15: 1215–1221
- Murase T, Yamaguchi M, Suzuki R, Okamoto M, Sato Y, Tamaru J I, et al. Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5. Blood 2007; 109: 478–485
- Bogomolski-Yahalom V, Lossos I S, Okun E, Sherman Y, Lossos A, Polliack A. Intravascular lymphomatosis—an indolent or aggressive entity?. Leuk Lymphoma 1998; 29: 585–593
- Vieren M, Sciot R, Robberecht W. Intravascular lymphomatosis of the brain: a diagnostic problem. Clin Neurol Neurosurg 1999; 101: 33–36
- Lopez-Yunez A, Vakili S, Witt T, Biller J. Diagnostic conundrum: a young woman with multifocal recurrent cerebral infarctions. Semin Cerebrovasc Dis Stroke 2002; 2: 84–88